Key facts
- This page summarizes David Platt's Form 4 filing for BIOXYTRAN, INC (BIXT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Aug 2022, 15:03.
David Platt - 16 Aug 2022 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)
- Reporting relationship
- CEO, Chairman, Director, 10%+ Owner
- Issuer ticker
- BIXT
- Reported as of
- 16 Aug 2022
- Net transaction value
- +$456
- SEC form
- 4
- Accepted by SEC
- 16 Aug 2022, 15:03:28 UTC
- Prior SEC filing
- 13 May 2022
- Next SEC filing
- 08 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- David Platt
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Platt filed Form 4 for BIOXYTRAN, INC (BIXT) on 16 Aug 2022.
Change
- Previous filing in this sequence was filed on 13 May 2022.
- Current net transaction value: +$456.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIXT
transaction
Common stock
Disposed to Issuer
- Transaction value
- $456
- Shares
- +455,669
- Change %
- +1%
- Price
- $0.001000*
- Shares after
- 45,962,806
- Date
- 16 Aug 2022
- Ownership
- Through NDPD Pharma, Inc.
* marks a reported price that did not pass the local price check.